Drug Interaction Report
1 potential interaction and/or warning found for the following 2 drugs:
- colesevelam
- Reltone (ursodiol)
Interactions between your drugs
ursodiol colesevelam
Applies to: Reltone (ursodiol), colesevelam
ADJUST DOSING INTERVAL: Bile acid sequestering agents may bind ursodiol (ursodeoxycholic acid) in the intestine, potentially reducing its absorption and efficacy.
MANAGEMENT: Ursodiol should not be administered simultaneously with a bile acid sequestering agent. The prescribing information for colesevelam recommends taking concomitant oral medications at least 4 hours before colesevelam. For concomitant medications that require administration via divided doses, it should be noted that the required dose of colesevelam may be given once a day. Additional monitoring of clinical effects may be considered in patients requiring combination therapy and appropriate adjustments made if clinically necessary.
References (8)
- (2024) "Product Information. Colesevelam Hydrochloride (colesevelam)." Ascend Laboratories, LLC
- (2024) "Product Information. Colesevelam (colesevelam)." Dr Reddy's Laboratories (UK) Ltd
- (2020) "Product Information. Lodalis (colesevelam)." Bausch & Lomb Canada Inc
- (2024) "Product Information. Ursodiol (ursodiol)." Watson Pharmaceuticals
- (2023) "Product Information. Ursodeoxycholic Acid (ursodeoxycholic acid)." Advanz Pharma
- (2024) "Product Information. Ursodox (GH) (ursodeoxycholic acid)." Lupin Australia Pty Ltd
- (2023) "Product Information. NRA-Ursodiol (ursodiol)." Nora Pharma Inc
- (2021) "Product Information. CHOLESTAGEL (colesevelam)." Cheplapharm Arzneimittel GmbH
Drug and food/lifestyle interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Leqvio
Leqvio is used in adults with primary hyperlipidemia to reduce low-density lipoprotein (LDL-C) ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Xifaxan
Xifaxan (rifaximin) is used to treat travelers' diarrhea, irritable bowel syndrome with diarrhea ...
Metamucil
Metamucil is used for constipation, dietary fiber supplementation, irritable bowel syndrome
Pepto-Bismol
Pepto-Bismol is antacid used to treat heart burn, indigestion, diarrhea, gas or an upset stomach ...
Imodium A-D
Imodium A-D is used to treat and control diarrhea, including traveler's diarrhea. Learn about side ...
Viberzi
Viberzi (eluxadoline) is used to treat irritable bowel Syndrome with Diarrhea (IBS-D). Includes ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.